CD19 and infection: Among 22 studies evaluating infections after CD19/BCMA CAR T-cell therapy, only 11 (50%) studies reported using the European Organisation for Research and Treatment of Cancer/Mycoses Study Group Education and Research Consortium (EORTC/MSGERC) Consensus Definitions for IFD.